CHARLES K. DARGAN - 23 Jun 2024 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Chief Financial Officer
Signature
/s/ John R. Browning, attorney-in-fact
Issuer symbol
BLGO
Transactions as of
23 Jun 2024
Transactions value $
$0
Form type
4
Filing time
25 Jun 2024, 17:59:40 UTC
Previous filing
19 Jul 2023
Next filing
15 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLGO Option to purchase common stock Award +700K +19.31% 4.33M 23 Jun 2024 Common stock 700K $0.27 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Option was granted to Reporting Person to replace an option to purchase 300,000 shares that had been issued approximately 10 years ago to compensate Reporting Person for services to the Issuer and had expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee.
F2 This total reflects the expiration of the option referenced in F1.